ConductScience.org, home

Paper17823767

Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline.

Speiser Z and 5 others. J Neural Transm (Vienna), 2008. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline. Papers, record 17823767. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17823767

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline.
PubMed
Journal
J Neural Transm (Vienna)
PubMed
Year
2008
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.29
iCite
Revised in PubMed
2026-01-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Speiser ZZ
2Fine TT
3Litinetsky LL
4Eliash SS
5Blaugrund EE
6Cohen SS

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FluoxetineMajor topic
Monoamine Oxidase InhibitorsMajor topic
Serotonin SyndromeMajor topic
Selective Serotonin Reuptake InhibitorsMajor topic
Animals
Behavior, Animal
Brain
Drug Therapy, Combination
Indans
Male
Methamphetamine
Rats
Rats, Sprague-Dawley
Selegiline

Source PubMed

Download CSV of topics

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11203627Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.Br J Pharmacol1975https://conductscience.org/library/papers/1203627PubMed
216256213Mice over-expressing the 5-HT(1A) receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT.Behav Brain Res2006https://conductscience.org/library/papers/16256213PubMed
311164765Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome.Brain Res2001https://conductscience.org/library/papers/11164765PubMed
4708990The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.Br J Pharmacol1978https://conductscience.org/library/papers/708990PubMed
512873279Serotonin syndrome and other serotonergic disorders.Pain Med2003https://conductscience.org/library/papers/12873279PubMed
612603236Death following ingestion of MDMA (ecstasy) and moclobemide.Addiction2003https://conductscience.org/library/papers/12603236PubMed
712925718The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity.QJM2003https://conductscience.org/library/papers/12925718PubMed
83308444Neuropeptide regulation of appetite and weight.Endocr Rev1987https://conductscience.org/library/papers/3308444PubMed
914520137Abnormal CSF monoamine metabolism in serotonin syndrome.J Clin Psychopharmacol2003https://conductscience.org/library/papers/14520137PubMed
10174872265-HT 1B receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats.Neuropsychopharmacology2008https://conductscience.org/library/papers/17487226PubMed
1116230Blockade of 5-hydroxytryptamine receptors in the central nervous system by beta-adrenoceptor antagonists.Neuropharmacology1977https://conductscience.org/library/papers/16230PubMed
12890205
Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
Br J Pharmacol1977https://conductscience.org/library/papers/890205PubMed
132902292Danger of MAOI therapy after fluoxetine withdrawal.Lancet1988https://conductscience.org/library/papers/2902292PubMed
1416488409Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats.Eur J Pharmacol2006https://conductscience.org/library/papers/16488409PubMed
1512504917Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours.Neuropharmacology2002https://conductscience.org/library/papers/12504917PubMed
163734795A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.J Neurochem1986https://conductscience.org/library/papers/3734795PubMed
1712649391Ambient temperature influences core body temperature response in rat lines bred for differences in sensitivity to 8-hydroxy-dipropylaminotetralin.J Pharmacol Exp Ther2003https://conductscience.org/library/papers/12649391PubMed
18157439275-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome.J Pharmacol Exp Ther2005https://conductscience.org/library/papers/15743927PubMed
199564630(R)(+)-N-propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase B.J Neural Transm Suppl1998https://conductscience.org/library/papers/9564630PubMed
2011127542Possible serotonin syndrome arising from an interaction between nortriptyline and selegiline in a lady with parkinsonism.J Neurol2000https://conductscience.org/library/papers/11127542PubMed

See all 47 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
33799684Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice.Int J Mol Sci2021https://conductscience.org/library/papers/33799684PubMed
24067924Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats.Neuropharmacology2014https://conductscience.org/library/papers/24067924PubMed
19464285Assessment of 5-hydroxytryptamine efflux in rat brain during a mild, moderate and severe serotonin-toxicity syndrome.Eur J Pharmacol2009https://conductscience.org/library/papers/19464285PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17823767

GET https://conductscience.org/api/papers/v1/17823767/references?page=2